2016 life sciences accounting and financial reporting update
Including interpretive guidance
Transformations in financial reporting present today’s life sciences finance professionals with unprecedented challenges. Changes to the accounting standards that affect how revenue is recognized and how “business” is defined could significantly impact the accounting for transactions. How can Deloitte help? Download our seventh-annual Life Sciences Accounting and Financial Reporting Update, which includes interpretive guidance on the issues affecting the industry, to learn more now.
The latest accounting and financial reporting issues
Life sciences companies have demonstrated their ability to survive and thrive amid recent periods of economic recession, health care spending cutbacks, geographic market swings, and changing population profiles. At the same time, transformations in financial reporting present today’s life sciences finance professionals with significant challenges.
Deloitte’s Life Sciences Accounting and Financial Reporting Update, which includes interpretive guidance, addresses a number of issues affecting today’s life sciences finance professionals including:
Complex areas of existing accounting standards related to:
- Revenue recognition
- Acquisitions and disposals
- Financial statement presentation and disclosure